No serious adverse events seen with gene therapy for X-linked retinoschisis – Healio
|
No serious adverse events seen with gene therapy for X-linked retinoschisis
Healio Patients with X-linked retinoschisis who underwent treatment with adeno-associated virus-based gene therapy developed no treatment-related serious adverse events through 12 months, according to interim safety data from a phase 1/2 trial. |
